Jamaica

Jamaica

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.27 (0.24 - 0.30) 2019 Modelled IHME
0.27 (0.24 - 0.30) 2018 Modelled IHME
0.27 (0.24 - 0.31) 2017 Modelled IHME
0.28 (0.25 - 0.32) 2016 Modelled IHME
0.29 (0.25 - 0.33) 2015 Modelled IHME
0.3 (0.26 - 0.34) 2014 Modelled IHME
0.3 (0.27 - 0.34) 2013 Modelled IHME
0.31 (0.27 - 0.35) 2012 Modelled IHME
0.31 (0.27 - 0.36) 2011 Modelled IHME
0.32 (0.28 - 0.37) 2010 Modelled IHME
0.33 (0.28 - 0.37) 2009 Modelled IHME
0.33 (0.29 - 0.38) 2008 Modelled IHME
0.34 (0.29 - 0.39) 2007 Modelled IHME
0.35 (0.29 - 0.40) 2006 Modelled IHME
0.35 (0.30 - 0.40) 2005 Modelled IHME
0.36 (0.30 - 0.41) 2004 Modelled IHME
0.36 (0.31 - 0.41) 2003 Modelled IHME
0.36 (0.31 - 0.42) 2002 Modelled IHME
0.37 (0.31 - 0.42) 2001 Modelled IHME
0.37 (0.32 - 0.43) 2000 Modelled IHME
0.37 (0.32 - 0.43) 1999 Modelled IHME
0.37 (0.32 - 0.43) 1998 Modelled IHME
0.38 (0.32 - 0.44) 1997 Modelled IHME
0.38 (0.32 - 0.44) 1996 Modelled IHME
0.38 (0.32 - 0.44) 1995 Modelled IHME
0.39 (0.33 - 0.45) 1994 Modelled IHME
0.39 (0.33 - 0.45) 1993 Modelled IHME
0.39 (0.33 - 0.46) 1992 Modelled IHME
0.4 (0.33 - 0.46) 1991 Modelled IHME
0.4 (0.34 - 0.47) 1990 Modelled IHME
0.49 (0.11 - 1.41) 2015 Modelled WHO
5 (2.40 - 5.70) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.01 (0.01 - 0.02) 2019 Modelled IHME
0.01 (0.01 - 0.02) 2018 Modelled IHME
0.01 (0.01 - 0.02) 2017 Modelled IHME
0.01 (0.01 - 0.02) 2016 Modelled IHME
0.02 (0.01 - 0.02) 2015 Modelled IHME
0.02 (0.01 - 0.02) 2014 Modelled IHME
0.02 (0.01 - 0.02) 2013 Modelled IHME
0.02 (0.01 - 0.03) 2012 Modelled IHME
0.02 (0.01 - 0.03) 2011 Modelled IHME
0.02 (0.02 - 0.03) 2010 Modelled IHME
0.03 (0.02 - 0.03) 2009 Modelled IHME
0.03 (0.02 - 0.04) 2008 Modelled IHME
0.03 (0.02 - 0.04) 2007 Modelled IHME
0.04 (0.03 - 0.05) 2006 Modelled IHME
0.04 (0.03 - 0.06) 2005 Modelled IHME
0.06 (0.05 - 0.09) 2004 Modelled IHME
0.1 (0.07 - 0.14) 2003 Modelled IHME
0.14 (0.11 - 0.20) 2002 Modelled IHME
0.18 (0.13 - 0.25) 2001 Modelled IHME
0.2 (0.14 - 0.27) 2000 Modelled IHME
0.2 (0.15 - 0.28) 1999 Modelled IHME
0.21 (0.15 - 0.28) 1998 Modelled IHME
0.21 (0.15 - 0.28) 1997 Modelled IHME
0.21 (0.15 - 0.28) 1996 Modelled IHME
0.22 (0.15 - 0.29) 1995 Modelled IHME
0.22 (0.15 - 0.29) 1994 Modelled IHME
0.22 (0.16 - 0.29) 1993 Modelled IHME
0.22 (0.16 - 0.30) 1992 Modelled IHME
0.23 (0.16 - 0.30) 1991 Modelled IHME
0.23 (0.16 - 0.30) 1990 Modelled IHME
0.16 (0.04 - 0.51) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
9,452 (7,967 - 11,067) 1990 Modelled IHME
9,429 (7,961 - 11,034) 1991 Modelled IHME
9,426 (7,995 - 10,987) 1992 Modelled IHME
9,437 (8,002 - 10,974) 1993 Modelled IHME
9,460 (8,042 - 10,981) 1994 Modelled IHME
9,494 (8,052 - 11,030) 1995 Modelled IHME
9,540 (8,124 - 11,071) 1996 Modelled IHME
9,591 (8,159 - 11,104) 1997 Modelled IHME
9,641 (8,209 - 11,150) 1998 Modelled IHME
9,680 (8,244 - 11,209) 1999 Modelled IHME
9,700 (8,263 - 11,278) 2000 Modelled IHME
9,700 (8,290 - 11,180) 2001 Modelled IHME
9,682 (8,261 - 11,107) 2002 Modelled IHME
9,646 (8,218 - 11,047) 2003 Modelled IHME
9,593 (8,150 - 11,011) 2004 Modelled IHME
9,523 (8,093 - 10,954) 2005 Modelled IHME
9,424 (8,016 - 10,760) 2006 Modelled IHME
9,289 (7,961 - 10,562) 2007 Modelled IHME
9,130 (7,843 - 10,327) 2008 Modelled IHME
8,963 (7,774 - 10,170) 2009 Modelled IHME
8,805 (7,661 - 10,056) 2010 Modelled IHME
8,663 (7,595 - 9,810) 2011 Modelled IHME
8,525 (7,481 - 9,611) 2012 Modelled IHME
8,388 (7,362 - 9,419) 2013 Modelled IHME
8,239 (7,242 - 9,335) 2014 Modelled IHME
8,073 (7,069 - 9,173) 2015 Modelled IHME
7,849 (6,884 - 8,883) 2016 Modelled IHME
7,667 (6,691 - 8,671) 2017 Modelled IHME
7,581 (6,648 - 8,513) 2018 Modelled IHME
7,546 (6,629 - 8,503) 2019 Modelled IHME
143,000 (69,000 - 164,000) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
1.2 (0.86 - 1.62) 2019 Modelled IHME
1.18 (0.86 - 1.57) 2018 Modelled IHME
1.17 (0.87 - 1.53) 2017 Modelled IHME
1.15 (0.89 - 1.50) 2016 Modelled IHME
1.15 (0.90 - 1.47) 2015 Modelled IHME
1.17 (0.94 - 1.45) 2014 Modelled IHME
1.15 (0.94 - 1.42) 2013 Modelled IHME
1.23 (1 - 1.51) 2012 Modelled IHME
1.41 (1.14 - 1.74) 2011 Modelled IHME
1.33 (1.08 - 1.62) 2010 Modelled IHME
1.5 (1.21 - 1.86) 2009 Modelled IHME
1.43 (1.15 - 1.77) 2008 Modelled IHME
1.23 (0.98 - 1.53) 2007 Modelled IHME
1.07 (0.86 - 1.33) 2006 Modelled IHME
1.05 (0.84 - 1.31) 2005 Modelled IHME
1.1 (0.89 - 1.36) 2004 Modelled IHME
1.17 (0.95 - 1.44) 2003 Modelled IHME
1.21 (0.97 - 1.50) 2002 Modelled IHME
1.21 (0.97 - 1.52) 2001 Modelled IHME
1.2 (0.96 - 1.51) 2000 Modelled IHME
1.27 (1.02 - 1.61) 1999 Modelled IHME
1.31 (1.04 - 1.65) 1998 Modelled IHME
1.35 (1.04 - 1.73) 1997 Modelled IHME
1.4 (1.07 - 1.82) 1996 Modelled IHME
1.41 (1.06 - 1.84) 1995 Modelled IHME
1.52 (1.15 - 1.97) 1994 Modelled IHME
1.57 (1.22 - 2) 1993 Modelled IHME
1.57 (1.25 - 1.98) 1992 Modelled IHME
1.57 (1.26 - 1.94) 1991 Modelled IHME
1.66 (1.34 - 2.05) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
34 (24 - 45) 2019 Modelled IHME
33 (24 - 44) 2018 Modelled IHME
33 (24 - 43) 2017 Modelled IHME
32 (25 - 42) 2016 Modelled IHME
32 (25 - 41) 2015 Modelled IHME
33 (26 - 40) 2014 Modelled IHME
32 (26 - 40) 2013 Modelled IHME
34 (28 - 42) 2012 Modelled IHME
39 (32 - 48) 2011 Modelled IHME
37 (30 - 45) 2010 Modelled IHME
41 (33 - 51) 2009 Modelled IHME
39 (31 - 49) 2008 Modelled IHME
34 (27 - 42) 2007 Modelled IHME
29 (23 - 36) 2006 Modelled IHME
28 (23 - 35) 2005 Modelled IHME
30 (24 - 37) 2004 Modelled IHME
31 (25 - 39) 2003 Modelled IHME
32 (26 - 40) 2002 Modelled IHME
32 (26 - 40) 2001 Modelled IHME
31 (25 - 40) 2000 Modelled IHME
33 (26 - 42) 1999 Modelled IHME
34 (27 - 42) 1998 Modelled IHME
34 (27 - 44) 1997 Modelled IHME
35 (27 - 46) 1996 Modelled IHME
35 (26 - 46) 1995 Modelled IHME
37 (28 - 48) 1994 Modelled IHME
38 (30 - 49) 1993 Modelled IHME
38 (30 - 48) 1992 Modelled IHME
38 (30 - 46) 1991 Modelled IHME
39 (32 - 48) 1990 Modelled IHME
97 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
26 (19 - 34) 2019 Modelled IHME
26 (19 - 34) 2018 Modelled IHME
26 (20 - 35) 2017 Modelled IHME
26 (20 - 35) 2016 Modelled IHME
26 (20 - 35) 2015 Modelled IHME
26 (20 - 35) 2014 Modelled IHME
27 (20 - 35) 2013 Modelled IHME
27 (21 - 36) 2012 Modelled IHME
28 (21 - 37) 2011 Modelled IHME
28 (21 - 37) 2010 Modelled IHME
29 (22 - 37) 2009 Modelled IHME
28 (21 - 37) 2008 Modelled IHME
27 (21 - 36) 2007 Modelled IHME
27 (20 - 36) 2006 Modelled IHME
27 (20 - 36) 2005 Modelled IHME
27 (20 - 36) 2004 Modelled IHME
27 (21 - 36) 2003 Modelled IHME
28 (21 - 36) 2002 Modelled IHME
27 (20 - 36) 2001 Modelled IHME
27 (20 - 36) 2000 Modelled IHME
28 (20 - 37) 1999 Modelled IHME
28 (21 - 37) 1998 Modelled IHME
28 (21 - 37) 1997 Modelled IHME
28 (21 - 37) 1996 Modelled IHME
28 (20 - 37) 1995 Modelled IHME
28 (21 - 37) 1994 Modelled IHME
28 (21 - 37) 1993 Modelled IHME
28 (21 - 37) 1992 Modelled IHME
28 (21 - 37) 1991 Modelled IHME
28 (21 - 37) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
97 2018 Survey/reported WHO/UNICEF
93 2017 Survey/reported WHO/UNICEF
98 2016 Survey/reported WHO/UNICEF
91 2015 Survey/reported WHO/UNICEF
92 2014 Survey/reported WHO/UNICEF
93 2013 Survey/reported WHO/UNICEF
96 2012 Survey/reported WHO/UNICEF
92 2011 Survey/reported WHO/UNICEF
94 2010 Survey/reported WHO/UNICEF
90 2009 Survey/reported WHO/UNICEF
92 2008 Survey/reported WHO/UNICEF
92 2007 Survey/reported WHO/UNICEF
97 2006 Survey/reported WHO/UNICEF
99 2005 Survey/reported WHO/UNICEF
98 2004 Survey/reported WHO/UNICEF
36 2003 Survey/reported WHO/UNICEF
96 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Planned for 2020
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
No
Source Harm Reduction International
At least one opioid substitution therapy (OST) program operational
No
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.64 (1.32 - 2.04) 2019 Modelled IHME
1.63 (1.31 - 2.01) 2018 Modelled IHME
1.61 (1.29 - 1.99) 2017 Modelled IHME
1.58 (1.27 - 1.96) 2016 Modelled IHME
1.56 (1.26 - 1.93) 2015 Modelled IHME
1.56 (1.25 - 1.93) 2014 Modelled IHME
1.55 (1.24 - 1.91) 2013 Modelled IHME
1.55 (1.24 - 1.91) 2012 Modelled IHME
1.55 (1.23 - 1.91) 2011 Modelled IHME
1.54 (1.23 - 1.91) 2010 Modelled IHME
1.54 (1.23 - 1.91) 2009 Modelled IHME
1.53 (1.23 - 1.90) 2008 Modelled IHME
1.53 (1.23 - 1.90) 2007 Modelled IHME
1.53 (1.23 - 1.90) 2006 Modelled IHME
1.52 (1.23 - 1.90) 2005 Modelled IHME
1.53 (1.23 - 1.90) 2004 Modelled IHME
1.54 (1.24 - 1.92) 2003 Modelled IHME
1.55 (1.24 - 1.93) 2002 Modelled IHME
1.56 (1.25 - 1.95) 2001 Modelled IHME
1.57 (1.24 - 1.96) 2000 Modelled IHME
1.56 (1.25 - 1.94) 1999 Modelled IHME
1.55 (1.24 - 1.94) 1998 Modelled IHME
1.53 (1.23 - 1.92) 1997 Modelled IHME
1.52 (1.22 - 1.90) 1996 Modelled IHME
1.52 (1.21 - 1.90) 1995 Modelled IHME
1.52 (1.22 - 1.89) 1994 Modelled IHME
1.52 (1.22 - 1.90) 1993 Modelled IHME
1.52 (1.22 - 1.90) 1992 Modelled IHME
1.53 (1.22 - 1.90) 1991 Modelled IHME
1.53 (1.23 - 1.91) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
36,283 (29,037 - 45,110) 1990 Modelled IHME
36,368 (29,053 - 45,324) 1991 Modelled IHME
36,583 (29,298 - 45,712) 1992 Modelled IHME
36,891 (29,615 - 46,050) 1993 Modelled IHME
37,269 (29,882 - 46,468) 1994 Modelled IHME
37,691 (30,131 - 47,101) 1995 Modelled IHME
38,259 (30,611 - 47,796) 1996 Modelled IHME
39,005 (31,191 - 48,701) 1997 Modelled IHME
39,803 (31,957 - 49,843) 1998 Modelled IHME
40,523 (32,468 - 50,426) 1999 Modelled IHME
41,032 (32,623 - 51,334) 2000 Modelled IHME
41,256 (32,973 - 51,428) 2001 Modelled IHME
41,278 (33,098 - 51,328) 2002 Modelled IHME
41,214 (33,318 - 51,306) 2003 Modelled IHME
41,172 (33,188 - 51,304) 2004 Modelled IHME
41,269 (33,355 - 51,324) 2005 Modelled IHME
41,502 (33,510 - 51,578) 2006 Modelled IHME
41,767 (33,681 - 51,821) 2007 Modelled IHME
42,031 (33,832 - 52,070) 2008 Modelled IHME
42,274 (33,794 - 52,351) 2009 Modelled IHME
42,497 (33,860 - 52,530) 2010 Modelled IHME
42,693 (34,107 - 52,710) 2011 Modelled IHME
42,880 (34,228 - 52,939) 2012 Modelled IHME
43,082 (34,528 - 53,139) 2013 Modelled IHME
43,299 (34,824 - 53,656) 2014 Modelled IHME
43,550 (35,211 - 53,784) 2015 Modelled IHME
44,195 (35,528 - 54,909) 2016 Modelled IHME
45,010 (36,254 - 55,641) 2017 Modelled IHME
45,599 (36,639 - 56,512) 2018 Modelled IHME
46,114 (37,158 - 57,370) 2019 Modelled IHME
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
1.93 (1.37 - 2.62) 2019 Modelled IHME
1.89 (1.36 - 2.56) 2018 Modelled IHME
1.86 (1.38 - 2.47) 2017 Modelled IHME
1.82 (1.40 - 2.39) 2016 Modelled IHME
1.8 (1.41 - 2.29) 2015 Modelled IHME
1.74 (1.39 - 2.19) 2014 Modelled IHME
1.58 (1.27 - 1.97) 2013 Modelled IHME
1.56 (1.26 - 1.93) 2012 Modelled IHME
1.66 (1.33 - 2.08) 2011 Modelled IHME
1.54 (1.22 - 1.92) 2010 Modelled IHME
1.74 (1.35 - 2.16) 2009 Modelled IHME
1.69 (1.32 - 2.11) 2008 Modelled IHME
1.5 (1.18 - 1.89) 2007 Modelled IHME
1.34 (1.04 - 1.67) 2006 Modelled IHME
1.33 (1.04 - 1.68) 2005 Modelled IHME
1.4 (1.11 - 1.76) 2004 Modelled IHME
1.5 (1.20 - 1.88) 2003 Modelled IHME
1.56 (1.24 - 1.95) 2002 Modelled IHME
1.59 (1.25 - 2) 2001 Modelled IHME
1.57 (1.24 - 1.97) 2000 Modelled IHME
1.64 (1.28 - 2.06) 1999 Modelled IHME
1.64 (1.28 - 2.11) 1998 Modelled IHME
1.68 (1.29 - 2.17) 1997 Modelled IHME
1.71 (1.31 - 2.24) 1996 Modelled IHME
1.73 (1.32 - 2.28) 1995 Modelled IHME
1.81 (1.36 - 2.36) 1994 Modelled IHME
1.84 (1.39 - 2.38) 1993 Modelled IHME
1.82 (1.41 - 2.29) 1992 Modelled IHME
1.79 (1.40 - 2.22) 1991 Modelled IHME
1.92 (1.52 - 2.39) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
54 (38 - 74) 2019 Modelled IHME
53 (38 - 72) 2018 Modelled IHME
52 (39 - 69) 2017 Modelled IHME
51 (39 - 67) 2016 Modelled IHME
50 (39 - 64) 2015 Modelled IHME
48 (39 - 61) 2014 Modelled IHME
44 (35 - 55) 2013 Modelled IHME
43 (35 - 54) 2012 Modelled IHME
46 (37 - 57) 2011 Modelled IHME
42 (34 - 53) 2010 Modelled IHME
48 (37 - 59) 2009 Modelled IHME
46 (36 - 58) 2008 Modelled IHME
41 (32 - 52) 2007 Modelled IHME
36 (28 - 45) 2006 Modelled IHME
36 (28 - 46) 2005 Modelled IHME
38 (30 - 47) 2004 Modelled IHME
40 (32 - 50) 2003 Modelled IHME
42 (33 - 52) 2002 Modelled IHME
42 (33 - 53) 2001 Modelled IHME
41 (32 - 52) 2000 Modelled IHME
43 (33 - 53) 1999 Modelled IHME
42 (33 - 54) 1998 Modelled IHME
43 (33 - 55) 1997 Modelled IHME
43 (33 - 56) 1996 Modelled IHME
43 (33 - 57) 1995 Modelled IHME
44 (33 - 58) 1994 Modelled IHME
45 (34 - 58) 1993 Modelled IHME
44 (34 - 55) 1992 Modelled IHME
43 (33 - 53) 1991 Modelled IHME
45 (36 - 57) 1990 Modelled IHME
48 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
24 (17 - 32) 2019 Modelled IHME
24 (17 - 31) 2018 Modelled IHME
24 (17 - 31) 2017 Modelled IHME
24 (17 - 31) 2016 Modelled IHME
24 (17 - 31) 2015 Modelled IHME
24 (18 - 31) 2014 Modelled IHME
24 (18 - 31) 2013 Modelled IHME
24 (17 - 31) 2012 Modelled IHME
23 (17 - 31) 2011 Modelled IHME
24 (17 - 31) 2010 Modelled IHME
23 (16 - 30) 2009 Modelled IHME
23 (17 - 31) 2008 Modelled IHME
24 (17 - 32) 2007 Modelled IHME
25 (18 - 32) 2006 Modelled IHME
25 (18 - 33) 2005 Modelled IHME
25 (18 - 33) 2004 Modelled IHME
25 (18 - 33) 2003 Modelled IHME
25 (18 - 32) 2002 Modelled IHME
25 (18 - 33) 2001 Modelled IHME
25 (17 - 33) 2000 Modelled IHME
24 (17 - 32) 1999 Modelled IHME
24 (17 - 32) 1998 Modelled IHME
24 (17 - 32) 1997 Modelled IHME
24 (17 - 32) 1996 Modelled IHME
24 (17 - 33) 1995 Modelled IHME
25 (17 - 32) 1994 Modelled IHME
25 (17 - 32) 1993 Modelled IHME
25 (18 - 32) 1992 Modelled IHME
25 (18 - 32) 1991 Modelled IHME
24 (17 - 32) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Planned for 2020
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
No
Source Harm Reduction International
At least one opioid substitution therapy (OST) program operational
No
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
Source: WHO

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
0.27 (%)
2019
(0.24 - 0.3(%))
IHME
HCV (RNA/cAg+)
1.64 (%)
2019
(1.32 - 2.04(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
34
2019
(24 - 45)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
54
2019
(38 - 74)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.01 (%)
2019, latest modelled
(0.01 - 0.02(%))
IHME

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources